CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Gift Director gave 15,000 shares (gift)
- 4 Open-market sale President and CEO sold 6,363 shares at $243.83 ($1,551,490)
- 144 Insider Sale of Securities
- 4 Grant or award General Counsel acquired 5,215 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 714 shares (grant or award)
- 4 Grant or award Director acquired 714 shares (grant or award)
- 4 Grant or award Director acquired 714 shares (grant or award)
- 4 Grant or award Director acquired 714 shares (grant or award)
- 4 Grant or award Director acquired 714 shares (grant or award)
- 4 Grant or award Director acquired 2,856 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale Senior VP, Chief Pharma Dev. sold 1,900 shares at $280.00 ($532,000)
- 4 Open-market sale Senior VP, Chief Pharma Dev. sold 2,000 shares at $285.00 ($570,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 12 of 62 · 1,224 filings